Last $51.35 USD
Change Today +0.64 / 1.26%
Volume 188.0K
ABAX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

abaxis inc (ABAX) Snapshot

Open
$50.85
Previous Close
$50.71
Day High
$51.57
Day Low
$50.15
52 Week High
09/19/14 - $53.98
52 Week Low
10/23/13 - $32.11
Market Cap
1.2B
Average Volume 10 Days
232.8K
EPS TTM
$0.70
Shares Outstanding
22.5M
EX-Date
08/29/14
P/E TM
73.4x
Dividend
$0.40
Dividend Yield
0.39%
Current Stock Chart for ABAXIS INC (ABAX)

abaxis inc (ABAX) Related Businessweek News

No Related Businessweek News Found

abaxis inc (ABAX) Details

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo Xpress chemistry analyzers with blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan HM5; and VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan Canine Heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma; VetScan Canine Lyme rapid test to detect Borrelia burgdorferi in canine whole blood, serum, or plasma; Vetscan Canine Parvovirus rapid test to detect canine parvovirus antigen in feces; and VetScan Giardia rapid test to detect Giardia cyst antigens in canine feces, as well as veterinary reference laboratory diagnostic and consulting services. Abaxis, Inc. sells its products through direct sales force and independent distributors. The company was founded in 1989 and is headquartered in Union City, California.

520 Employees
Last Reported Date: 05/30/14
Founded in 1989

abaxis inc (ABAX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $478.1K
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $258.5K
Chief Operations Officer
Total Annual Compensation: $258.5K
Chief Technology Officer
Total Annual Compensation: $258.5K
Compensation as of Fiscal Year 2014.

abaxis inc (ABAX) Key Developments

Abaxis, Inc. Announces Board Changes

Vladimir E. Ostoich, Ph.D., the Vice President of Government Affairs, Vice President of Marketing for the Pacific Rim and Co-Founder of Abaxis, Inc., has notified the company that he is retiring in such capacity effective September 30, 2014, and Dr. Ostoich's functions will be taken over by Achim Henkel, Managing Director of Abaxis Europe GmbH. In connection with Dr. Ostoich's retirement, the company entered into a Transition/Separation Agreement with Dr. Ostoich, dated August 15, 2014. Pursuant to this agreement, Dr. Ostoich will remain with the Company as a part-time employee until May 15, 2015.

Abaxis, Inc. Presents at C.L. King's Best Ideas Conference 2014, Sep-09-2014 12:30 PM

Abaxis, Inc. Presents at C.L. King's Best Ideas Conference 2014, Sep-09-2014 12:30 PM. Venue: Omni Berkshire Place Hotel, New York, New York, United States. Speakers: Clinton H. Severson, Chairman, Chief Executive Officer and President.

Abaxis, Inc. Declares Quarterly Cash Dividend, Payable on September 17, 2014

Abaxis, Inc. announced that its Board of Directors declared a quarterly dividend of $0.10 per common share to be paid on September 17, 2014, to all shareholders of record as of the close of business on September 3, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABAX:US $51.35 USD +0.64

ABAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Corgenix Medical Corp $0.25 USD +0.0009
Heska Corp $12.69 USD -0.50
Millennium Healthcare Inc $0.42 USD -0.0101
PetMed Express Inc $13.52 USD -0.08
View Industry Companies
 

Industry Analysis

ABAX

Industry Average

Valuation ABAX Industry Range
Price/Earnings 73.1x
Price/Sales 6.4x
Price/Book 5.8x
Price/Cash Flow 72.9x
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABAXIS INC, please visit www.abaxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.